123 related articles for article (PubMed ID: 4997883)
21. Vitiligo and malignant melanoma: a significant association?
Gregor RT
S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
[TBL] [Abstract][Full Text] [Related]
22. Hormones, immunology, nevi, and melanoma.
McLean DI; Gallagher RP
Arch Dermatol; 1997 Jun; 133(6):783-4. PubMed ID: 9197839
[No Abstract] [Full Text] [Related]
23. [Tyrosinases of nevo-cellular nevi and human malignant malanomas].
Voulot C; Ortonne JP
Ann Dermatol Syphiligr (Paris); 1975; 102(5-6):547-51. PubMed ID: 821383
[No Abstract] [Full Text] [Related]
24. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
[No Abstract] [Full Text] [Related]
25. Tyrosinase isoenzymes in six agaric species of Basidiomycetes.
Madhosingh C
Can J Microbiol; 1970 Sep; 16(9):895-9. PubMed ID: 4990159
[No Abstract] [Full Text] [Related]
26. Electrophoretic variations of tyrosinase in follilar melanocytes during the hair growth cycle in mice.
Burnett JB; Holstein TJ; Quevedo WC
J Exp Zool; 1969 Jul; 171(3):369-76. PubMed ID: 4981586
[No Abstract] [Full Text] [Related]
27. [Immunochemical study of soluble proteins extracted from hamster achromic melanoma].
Kleisbauer JP; Poirier R; Meyer G
C R Seances Soc Biol Fil; 1971; 165(4):933-6. PubMed ID: 4259512
[No Abstract] [Full Text] [Related]
28. [Immunohistologic detection of bullous pemphigoid antigen in malignant melanoma].
Hamm G; Reiss CJ
Dermatol Monatsschr; 1985; 171(12):788-92. PubMed ID: 3912222
[No Abstract] [Full Text] [Related]
29. Multiple forms of tyrosinase from human melanoma.
Burnett JB; Seiler H
J Invest Dermatol; 1969 Feb; 52(2):199-203. PubMed ID: 4975466
[No Abstract] [Full Text] [Related]
30. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
31. A modified DOPA reaction for the diagnosis and investigation of pigment cells.
Rodriguez HA; Mcgavran MH
Am J Clin Pathol; 1969 Aug; 52(2):219-27. PubMed ID: 4978978
[No Abstract] [Full Text] [Related]
32. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
33. Tyrosinase activity in a highly pigmented human melanoma and in negro skin.
Chen YM; Chavin W
Proc Soc Exp Biol Med; 1974 Feb; 145(2):695-8. PubMed ID: 4205290
[No Abstract] [Full Text] [Related]
34. [Quantitative analysis of changes in immune system indices in pigmented neoplasms in man].
Babakova SV; Kuznetsov VA; Kondratov AA; Gorodilova VV; Ageenko AI
Sov Med; 1985; (8):33-7. PubMed ID: 4059985
[No Abstract] [Full Text] [Related]
35. [Malignant melanoma and HIV infection].
Rasokat H; Steigleder GK; Bendick C; Müller S; Meller M
Z Hautkr; 1989 Jul; 64(7):581-2, 587. PubMed ID: 2528242
[TBL] [Abstract][Full Text] [Related]
36. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi.
Baranda L; Torres-Alvarez B; Moncada B; Portales-Pérez D; de la Fuente H; Layseca E; González-Amaro R
J Am Acad Dermatol; 1999 Oct; 41(4):567-72. PubMed ID: 10495377
[TBL] [Abstract][Full Text] [Related]
37. [Dysplastic pigmented nevi as a high risk group for the development of malignant melanoma].
Kik A; Kowalewska Z; Pawińska M
Przegl Dermatol; 1986; 73(4):323-6. PubMed ID: 3333866
[No Abstract] [Full Text] [Related]
38. [On some morpho-clinical criteria for evaluation of malignant transformation of cutaneous nevi].
Dobrescu G; Bârsu M; Florea N; Dobrescu A
Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):809-16. PubMed ID: 4798609
[No Abstract] [Full Text] [Related]
39. Make PEEC, not war: does evasive transdifferentiation protect from carcinogenesis?
Goerdt S
Med Hypotheses; 2001 Jul; 57(1):115-9. PubMed ID: 11421638
[TBL] [Abstract][Full Text] [Related]
40. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
Brandt O; Christophers E; Fölster-Holst R
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S101-4. PubMed ID: 15858503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
